BlackRock ETF Trust
02/23/2026 | Press release | Distributed by Public on 02/23/2026 15:39
Prospectus by Investment Company (Form 497)
BlackRock ETF Trust
iShares Health Innovation Active ETF
(the "Fund")
Supplement dated February 23, 2026 to the Summary Prospectus and the
Prospectus of the Fund, each dated November 28, 2025, as amended or supplemented to date
Effective February 24, 2026, the following changes are made to the Fund's Summary Prospectus and Prospectus, as applicable:
The section of the Summary Prospectus and the Prospectus entitled "Summary of Principal Risks" is amended to add the following:
Focus Risk. Under normal circumstances, the Fund focuses its investments in the securities of a limited number of issuers. This may subject the Fund to greater issuer-specific risk and potential losses than a fund that invests in the securities of a greater number of issuers.
The section of the Prospectus entitled "More Information About the Fund - A Further Discussion of Principal Risks" is amended to add the following:
Focus Risk. Under normal circumstances, the Fund focuses its investments in the securities of a limited number of issuers. This may subject the Fund to greater issuer-specific risk and potential losses than a fund that invests in the securities of a greater number of issuers.
Shareholders should retain this Supplement for future reference.
PR2-BMED-0226SUP
BlackRock ETF Trust published this content on February 23, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 23, 2026 at 21:39 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]